Biotech Specialty Pharma

Zelos Therapeutics

One Tower Bridge, 100 Front Street, Suite 1325, West
Conshohocken, PA 19428 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Treatments for osteoporosis, psoriasis and other diseases.

Management Brian MacDonald, M.B., Ch.B., Ph.D., Chief Executive Officer; David Krause, M.D., Senior Vice President and Head of R&D Chief Medical Officer; Alan S. Roemer, Chief Financial Officer

Click here for Financial Data
Keywords: Osteoporosis, Fracture repair, Spine fusion, Renal bone disease, Ostabolin, Forteo


Updated: Feb. 03, 2009


Zelos Therapeutics is developing medications for the treatment of osteoporosis, psoriasis and for enhancing engraftment following stem cell transplantation.......view more

Products / Services

Zelos' lead program, injectable Ostabolin-C for the treatment of osteoporosis, completed a series of three Phase I trials in Canada in 2004-05 and began Phase II testing at hospital and clinic sites i......view more